Agents with dual activity as angiotensin II antagonists and ACAT inhibitors discovered at Pola April 14, 2003
Good safety profile described for an adenovirus-VEGF construct in advanced coronary disease April 14, 2003
Improvement in metabolic syndrome upon chronic treatment with adenosine receptor antagonist April 9, 2003
RSS